NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$123.96
Tradestie Score
57
Market Cap
$5.95B
Analyst Upside
+0.9%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$34.91
|
$10.76B | - | 64 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$67.44
|
$10.74B | - | 57 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.64
|
$10.53B | 42.5 | 65 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.93
|
$10.49B | - | 45 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$84.09
|
$10.22B | - | 61 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$536.86
|
$10.01B | - | 64 | Compare |
|
TECH
Bio-Techne Corp.
|
$71.23
|
$9.33B | 101.9 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$90.47
|
$8.88B | 262.5 | 60 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$75.05
|
$8.77B | 26.7 | 59 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$184.97
|
$8.57B | - | 57 | Compare |
More NUVL Analysis
Data updated: Jul 14, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry